Difference between revisions of "Part:BBa K4421030"
Line 13: | Line 13: | ||
===The mechanism and usage of pSV40-UAS-iCASP9-2A-GFP=== | ===The mechanism and usage of pSV40-UAS-iCASP9-2A-GFP=== | ||
− | This part is placed downstream of NFAT_RE-Gal4-KRAB(<partinfo>BBa_K4421029</partinfo>) and the presence of Gal4-KRAB can inhibit the promotor pSV40-UAS, thus diminishing the synthesis of the iCASP9.The engineered cells can survive if the concentration of iCASP9 | + | This part is placed downstream of NFAT_RE-Gal4-KRAB(<partinfo>BBa_K4421029</partinfo>) and the presence of Gal4-KRAB can inhibit the promotor pSV40-UAS(<partinfo>BBa_K4040003</partinfo>), thus diminishing the synthesis of the iCASP9(<partinfo>BBa_K4421002</partinfo>).The engineered cells can survive if the concentration of iCASP9 is low enough after AP1903 addition. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 06:58, 16 July 2022
pSV40-UAS-iCASP9-2A-GFP
An inducible caspase-9 suicide gene was placed under the control of a combined UAS-SV40 promoter. The GFP tag serves as a reporter and the 2A peptide sequence was intercalated between iCASP9 and the GFP tag to allow the fusion peptide chain to separate into two peptide chains.
The mechanism and usage of pSV40-UAS-iCASP9-2A-GFP
This part is placed downstream of NFAT_RE-Gal4-KRAB(BBa_K4421029) and the presence of Gal4-KRAB can inhibit the promotor pSV40-UAS(BBa_K4040003), thus diminishing the synthesis of the iCASP9(BBa_K4421002).The engineered cells can survive if the concentration of iCASP9 is low enough after AP1903 addition.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 781
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 463
Illegal BsaI.rc site found at 1603
Illegal BsaI.rc site found at 2514